Treatment patterns in homozygous familial hypercholesterolemia: Undertreatment and delayed adoption of low-density lipoprotein receptor–independent therapies

American Journal of Preventive Cardiology · Published 2026-08-01 · DOI 10.1016/j.ajpc.2026.101778

Free full text

Authors (6)

Dana J. Murdock, Li Wang, Jing Gu, Robert J. Sanchez, Richard Godin, Eric J. Brandt

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Murdock, D., Wang, L., Gu, J., et al. (2026). Treatment patterns in homozygous familial hypercholesterolemia: Undertreatment and delayed adoption of low-density lipoprotein receptor–independent therapies. American Journal of Preventive Cardiology. https://doi.org/10.1016/j.ajpc.2026.101778

Related articles

• Impact of High-sensitivity C-reactive protein testing on statin use in primary prevention: A national multicenter analysis · American Journal of Preventive Cardiology · 2026 · Same journal
• Association of reproductive factors with acute myocardial infarction in young women: A VIRGO and NHANES case-control study · American Journal of Preventive Cardiology · 2026 · Same journal
• Incretin therapy prescription in a high cardiovascular risk population: Insights from a cardiology-based cardiometabolic program · American Journal of Preventive Cardiology · 2026 · Same journal
• Beyond place: Neighborhood deprivation, cardiometabolic health, and the life course origins of hypertensive disorders of pregnancy · American Journal of Preventive Cardiology · 2026 · Same journal
• Absence of significant coronary artery disease does not eliminate smoking-related cardiovascular risk: insights from the PROMISE trial · American Journal of Preventive Cardiology · 2026 · Same journal
• Don’t sleep on the other beds: Atherosclerosis across heart, brain, and limbs · American Journal of Preventive Cardiology · 2026 · Same journal
• Prevalence and predictors of silent atherosclerosis across life: Design of the REACT Phase 1 study · American Journal of Preventive Cardiology · 2026 · Same journal
• Real-world prescribing patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Type 2 diabetes with various ASCVD subtypes from a large tertiary referral center · American Journal of Preventive Cardiology · 2026 · Same journal
• Effectiveness of Yoga-based guided meditation In Improving the quality of sleep in patients with coronary artery disease: The Yoga Nidra Trial · American Journal of Preventive Cardiology · 2026 · Same journal
• The Coverage Gap in PREVENT: Why Cardiovascular Risk Prediction Needs a Lab-Free Complement · American Journal of Preventive Cardiology · 2026 · Same journal